Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

Go back to Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

Danaher (DHR) PT Raised to $125 at Baird

February 26, 2019 9:15 AM EST

Baird analyst Richard Eastman raised the price target on Danaher (NYSE: DHR) to $125.00 (from $114.00) while maintaining an Outperform rating following the announced GE Biopharma acquisition. Eastman views the acquisition as attractive.

Adjusting for ~$1.4B in NPV tax benefits to DHR, the purchase price... More